Challenges in the Clinical Application of the American Society of Clinical Oncology Value Framework: A Medicare Cost-Benefit Analysis in Chronic Lymphocytic Leukemia

The ASCO Value Framework calculates the value of cancer therapies. Given costly novel therapeutics for chronic lymphocytic leukemia, we used the framework to compare net health benefit (NHB) and cost within Medicare of all regimens listed in the National Comprehensive Cancer Network (NCCN) guideline...

Descripción completa

Detalles Bibliográficos
Autores principales: Seymour, Erlene K., Schiffer, Charles A., de Souza, Jonas A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2017
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797243/
https://www.ncbi.nlm.nih.gov/pubmed/29144866
http://dx.doi.org/10.1200/JOP.2017.024778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797243/
https://www.ncbi.nlm.nih.gov/pubmed/29144866
http://dx.doi.org/10.1200/JOP.2017.024778

Ejemplares similares